Unraveling the local influence of tumor-surrounding adipose tissue on tumor progression: Cellular and molecular actors involved

Adipose tissue and cancer

Volumn , Issue , 2013, Pages 121-146

  Muller, Catherine ^a,b   Nieto, Laurence ^a,b   Valet, Philippe ^a,c  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929528219     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-7660-3_7     Document Type: Chapter

References (134)

1. Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4(11):839-49.
2. Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008;9(8):628-38.
3. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392-401.
4. Mantovani A et al. Cancer-promoting tumor-Associated macrophages: new vistas and open questions. Eur J Immunol. 2011;41(9):2522-5.
5. Bjorndal B et al. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes. 2011;2011:490650.
6. Ouchi N et al. Adipokines in infl ammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85-97.
7. Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physi ol. 2012;302(2): C327-59.
8. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am. 2008;37(3):753-68. x-xi.
9. Walter M et al. Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene. 2009;28(30):2745-55.
10. Dirat B et al. Cancer-Associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71(7):2455-65.
11. Iyengar P,et al. Adipocyte-derived collagen VI affects early m ammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment J Clin Invest. 2005 115, 5, 1163-76.
12. Andarawewa KL et al. Stromelysin-3 is a potent ne gative regulator of adipogenesis participating to cancer cell-Adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res. 2005;65(23):10862-71.
13. Nieman KM et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498-503.
14. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-91.
15. Gir P et al. Human adipose stem cells: current clinical applications. Plast Reconstr Surg. 2012;129(6):1277-90.
16. Zhang Y, Bellows CF, Kolonin MG. Adipose tissue-derived progenitor cells and cancer. World J Stem Cells. 2010;2(5):103-13.
17. Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293(2):E444-52.
18. Kozak LP, Koza RA, Anunciado-Koza R. Brown fat thermogenesis and body weight regulation in mice: relevance to humans. Int J Obes (Lond). 2010;34 Suppl 1:S23-7.
19. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121):881-7.
20. Hotamisligil GS. Infl ammation and metabolic disorders. Nature. 2006;444(7121):860-7.
21. Zierath JR et al. Regional difference in insulin inhibition of non-esterifi ed fatty acid releas e from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia. 1998;41(11):1343-54.
22. Lafontan M, Lan gin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res. 2009;48(5):275-97.
23. Zhang Y et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425-32.
24. Van Harmelen V et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47(6):913-7.
25. Kadowaki T et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784-92.
26. Drolet R et al. Fat depot-specifi c impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring). 2009;17(3):424-30.
27. Fontana L et al. Visceral fat adipokine secretion is associated with systemic infl ammation in obese humans. Diabetes. 2007;56(4):1010-3.
28. Fain JN et al. Compa rison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145(5):2273-82.
29. L edoux S et al. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes. 2008;57(12):3247-57.
30. Lafontan M. Fat cells: afferent and efferent messages defi ne new approaches to treat obesity. Annu Rev Pharmacol Toxicol. 2005;45:119-46.
31. Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010;34(6):949-59.
32. Smith SR,et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obes ity Metabolism. 2001, 50, 4, 425-35.
33. Sbarbati A et al. Subcutaneous adipose tissue classifi cation. Eur J Histochem. 2010;54(4):e48.
34. Krings A et al. Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone. 2012;50(2):546-52.
35. Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone. 2012;50(2):534-9.
36. Naveiras O et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009;460(7252):259-63.
37. Rajsheker S et al. Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol. 2010;10(2):191-6.
38. Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids. 2005;73(1):17-30.
39. Hovey RC, Aimo L. Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia. 2010;15(3):279-90.
40. Wang YY et al. Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer. Cancer Lett. 2012;324(2):142-51.
41. Fata JE, Werb Z, Bissell MJ. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res. 2004;6(1):1-11.
42. Elliott BE et al. Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int J Cancer. 1992;51(3):416-24.
43. Manabe Y et al. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol. 2003;201(2):221-8.
44. Dirat B et al. Unraveling the obesity and breast cancer links: a role for cancer-Associated adipocytes? Endocr Dev. 2010;19:45-52.
45. Bochet L et al. Cancer-Associated adipocytes promotes breast tumor radioresistance. Biochem Biophys Res Commun. 2011;411(1):102-6.
46. Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev. 2011;32(4):550-70.
47. Motrescu ER, Rio MC. Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle. Biol Chem. 2008;389(8):1037-41.
48. Iyengar P et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-Apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene. 2003;22(41):6408-23.
49. Khan T et al. Metabolic dysregulation and adipose tissue fi brosis: role of collagen VI. Mol Cell Biol. 2009;29(6):1575-91.
50. Mot rescu ER et al. Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene. 2008;27(49): 6347-55.
51. Finley DS et al. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol. 2009;182(4):1621-7.
52. Divoux A, Clement K. Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes Rev. 2011;12(5):e494-503.
53. Subbaramaiah K,et al. Obesity is associated with infl ammation and elevated aromatase expression in the mouse mammary gland Cancer Prev Res (Phila 2011, 4, 3, 329-46.
54. Morris PG et al. Infl ammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). 2011;4(7):1021-9.
55. Dunlap SM et al. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-li ke mammary tumor models. Cancer Prev Res (Phila). 2012;5(7):930-42.
56. Dogan S et al. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-Alpha mice. Breast Cancer Res. 2007;9(6):R91.
57. Zhang Y et al. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res. 2009;69(12):5259-66.
58. Kidd S et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One. 2012;7(2):e30563.
59. Chandler EM et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci USA. 2012;109(25):9786-91.
60. Devarajan E et al. E pithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int J Cancer. 2012;131(5):1023-31.
61. Zhao M et al. Multipotent adipose stromal cells and breast cancer development: think globally, act locally. Mol Carcinog. 2010;49(11):923-7.
62. Petit JY et al. Locoregional recurrence risk after lipofi lling in breast cancer patients. Ann Oncol. 2012;23(3):582-8.
63. Bertolini F et al. Adipose tissue cells, lipotransfer and cancer: a challenge for scientists, oncologists and surgeons. Biochim Biophys Acta. 2012;1826(1):209-14.
64. Donnenberg VS et al. Regenerative therapy after cancer: what are the risks? Tissue Eng Part B Rev. 2010;16(6):567-75.
65. Martin-Padura I et al. The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression. Cancer Res. 2012;72(1): 325-34.
66. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351(24):2519-29.
67. Cai J et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis. 2012;33(1):20-9.
68. Sorensen EW et al. Omental immune aggregates and tumor metastasis within the peritoneal cavity. Immunol Res. 2009;45(2-3):185-94.
69. Smathers RL, Petersen DR. The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics. 2011;5(3):170-91.
70. Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Power surge: supporting cells " fuel" cancer cell mitochondria. Cell Metab. 2012;15(1):4-5.
71. Gazi E et al. Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res. 2007;48(8):1846-56.
72. Cho JA et al. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal st em cells to acquire the physical and functional characteristics of tumor-supporting myofi broblasts. Gynecol Oncol. 2011;123(2):379-86.
73. Jeon ES et al. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofi broblast-like cells. Stem Cells. 2008;26(3):789-97.
74. Valet P et al. Alpha2-Adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest. 1998;101(7):1431-8.
75. Jeon ES,et al. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells Exp Mol Med. 2010, 42, 4, 280-93.
76. Protani MM, Nagle CM, Webb PM. Obesity and ovarian cancer survival: a systematic review and meta-Analysis. Cancer Prev Res (Phila). 2012;5(7):901-10.
77. Schmandt RE et al. Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol. 2011;205(6):518-25.
78. Klopp AH et al. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res. 2012;18(3):771-82.
79. Swindle P et al. Do margins matter? The prognostic signifi cance of positive surgical margins in radical prostatectomy specimens. J Urol. 2005;174(3):903-7.
80. Magi-Galluzzi C et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Patho l. 2011;24(1):26-38.
81. Azevedo A et al. IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol. 2011;2(12):384-96.
82. Ribeiro RJ et al. Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profi le. Cell Physiol Biochem. 2012;29(1-2):233-40.
83. Ribeiro R et al. Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. J Exp Clin Cancer Res. 2012;31(1):32.
84. Prantl L et al. Adipose tissu e-derived stem cells promote prostate tumor growth. Prostate. 2010;70(15):1709-15.
85. Neugut AI, Chen AC, Petrylak DP. The " skinny" on obesity and prostate cancer prognosis. J Clin Oncol. 2004;22(3):395-8.
86. van Roermund JG et al. Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients. BJU Int. 2011;107(11):1775-9.
87. McGuire BB, Fitzpatrick JM. BMI and the risk of renal cell carcinoma. Curr Opin Urol. 2011;21(5):356-61.
88. Stewart SB, Freedland SJ. Infl uence of obesity on the incidence and treatment of genitourinary malignancies. Urol Oncol. 2011;29(5):476-86.
89. Doyle SL et al. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc. 2012;71(1):181-9.
90. Notarnicola M et al. Low levels of lipogenic enzymes in peritumoral adipose tissue of colorectal cancer patients. Lipids. 2012;47(1):59-63.
91. Amemori S et al. Adip ocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2007;292(3):G923-9.
92. Hoda MR et al. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg. 2007;94(3):346-54.
93. Jaffe T, Schwartz B. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer. 2008;123(11):2543-56.
94. Ratke J et al. Leptin stimulates the migration of colon carcinoma cells by multiple signaling pathways. Endocr Relat Cancer. 2010;17(1):179-89.
95. Bartucci M et al. Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fl uorouracil in colorectal tumor stem cells. Endocr Relat Cance r. 2010;17(3): 823-33.
96. Larsson SC,Wolk A. Obesity and colon and rectal cancer risk: a meta-Analysis of prospective studies Am J Clin Nutr. 2007, 86, 3, 556-65.
97. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a metaanalysis of 31 studies with 70, 000 events. Cancer Epidemiol Biomarkers Prev. 2007;16(12): 2533-47.
98. Renehan AG et al. Body-mass index and incidence of cancer: a systematic review and metaanalysis of prospective observational studies. Lancet. 2008;371(9612):569-78.
99. Sung MK et al. Obes ity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci. 2011;1229:61-8.
100. Park SY et al. Effects of diet-induced obesity on colitis-Associated colon tumor formation in A/J mice. Int J Obes (Lond). 2012;36(2):273-80.
101. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556-65.
102. Lysaght J et al. Pro-infl ammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Lett. 2011;312(1):62-72.
103. Nomoto-Kojima N et al. Interaction between adipose tissue stromal cells and gastric cancer cells in vitro. Cell Tissue Res. 2011;344(2):287-98.
104. Muller A et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50-6.
105. Zhao BC et al. Adipose-derived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis. Hepatogastroenterology. 2010;57(104):1382-9.
106. Calle EE et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-38.
107. Jamieson NB et al. Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2011;15(3):512-24.
108. Balentine CJ et al. Intra-Abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg. 2010;14(11):1832-7.
109. Mathur A et al. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg. 2009;208(5):989-94. discussion 994-6.
110. Grippo PJ et al. Concurrent PEDF defi ciency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut. 2012;61(10):1454-64.
111. White PB et al. Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J Gastrointest Surg. 2010;14(12):1888-93. discussion 1893-4.
112. Zyromski NJ et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery. 2009;146(2):258-63.
113. Cousin B et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One. 2009;4(7):e6278.
114. Bandarchi B et al. From melanocyte to metastatic malignant melanoma. Dermatol Res Pract. 2010;2010:583748.
115. Forsea AM et al. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124-30.
116. Villanueva J, Herlyn M. Melanoma and the tumor microenvironment. Curr Oncol Rep. 2008;10(5):439-46.
117. Gray-Schopfer V,Wellbrock C,Marais R. Melanoma biology and new targeted therapy Nature. 2007, 445, 7130, 851-7.
118. Smolle J et al. Pathology of tumor-stroma interaction in melanoma metastatic to the skin. Hum Pathol. 1995;26(8):856-61.
119. Wagner M et al. Infl amed tumor-Associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis. 2012;15(3):481-95.
120. Hollander DM et al. Demonstration of lipolytic activity from cultured human melanoma cells. J Surg Res. 1986;40(5):445-9.
121. Kushiro K, Nunez NP. Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells. Clin Exp Metastasis. 2011;28(8):877-86.
122. Dennis LK et al. Cutaneous mel anoma and obesity in the Agricultural Health Study. Ann Epidemiol. 2008;18(3):214-21.
123. Sharma SD, Katiyar SK. Leptin defi ciency-induced obesity exacerbates ultraviolet B radiation-induced cyclo oxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol. 2010;244(3):328-35.
124. Brandon EL et al. Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther. 2009;8(19):1871-9.
125. Pandey V et al. Diet-induced obesity increases melanoma progression: involvement of Cav-1 and FASN. Int J Cancer. 2012;130(3):497-508.
126. Mori A et al. Severe pulmonary metastasis in obese and diabetic mice. Int J Cancer. 2006;119(12):2760-7.
127. Askmyr M, Quach J, Purton LE. Effects of the bone marrow microenvironment on hematopoietic malignancy. Bone. 2011;48(1):115-20.
128. Hino M et al. Leptin receptor and leukemia. Leuk Lymphoma. 2000;36(5-6):457-61.
129. Laharrague P et al. High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J. 1998;12(9):747-52.
130. Behan JW et al. Adipocy tes impair leukemia treatment in mice. Cancer Res. 2009;69(19): 7867-74.
131. Gelelete CB et al. Overweight as a prognostic factor in children with acute lymphoblastic leukemia. Obesity (Silver Spring). 2011;19(9):1908-11.
132. Castillo JJ et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-Analysis of prospective cohort studies. Leuk Res. 2012;36(7):868-75.
133. Medeiros BC et al. Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia. Haematologica. 2012;97(9):1401-4.
134. Caers J et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia. 2007;21(7):1580-4.